A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/155 (2006.01) A61K 31/166 (2006.01) A61K 31/18 (2006.01) A61K 31/33 (2006.01) A61K 31/38 (2006.01) A61K 31/40 (2006.01) A61K 31/445 (2006.01) A61K 31/47 (2006.01) A61K 45/00 (2006.01)
Patent
CA 2257299
The active substances identified as inhibitors of the cellular Na+/H+ exchanger (NHE) are used to prepare a medicament for normalizing serum lipids. They are used in the preparation of a medicament which reduces lipid levels in the blood and can be administered for treating diseases caused by lipid levels which are too high, and for alleviating the endothelial dysfunctional syndrome and for treating diseases caused thereby.
Les principes actifs identifiés comme inhibiteurs de l'échangeur cellulaire Na<+>H<+> (NHE) sont utilisés pour préparer un médicament servant à normaliser les lipides sériques. Ils s'utilisent dans la préparation d'un médicament permettant d'abaisser le taux de lipides dans le sang et par conséquent de traiter les maladies induites par des taux trop élevés, et de réduire le syndrome dysfonctionnel endothélial de traiter les maladies qu'il induit.
Falk Eugen
Jansen Hans-Willi
Jung Oliver
Kleemann Heinz-Werner
Kramer Werner
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Hoechst Aktiengesellschaft
LandOfFree
Use of inhibitors of the cellular na+/h+ exchanger (nhe) for... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of inhibitors of the cellular na+/h+ exchanger (nhe) for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of inhibitors of the cellular na+/h+ exchanger (nhe) for... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1961089